Results 131 to 136 of about 403 (136)

On Schopenhauer's Debt to Spinoza1

open access: yesEuropean Journal of Philosophy, EarlyView.
Abstract Schopenhauer offers ‘nature is not divine but demonic’ as a direct rebuttal of Spinoza's pantheism, his identification of ‘nature’ with ‘God’. And so, one would think, he ought to have been immune to the ‘Spinozism’ that became, as Heine called it, ‘the unofficial religion’ of the age.
Julian Young
wiley   +1 more source

May I pick your brain? Local minds as living cadastres in a Portuguese eleventh‐century lawsuit

open access: yesEarly Medieval Europe, EarlyView.
In the context of a dispute with the monastery of Lorvão, in the late eleventh century, the monks of Vacariça, near Coimbra (modern Portugal), carried out a field enquiry in the village of Recardães. This was part of a failed attempt to repossess a number of land plots that they claimed were theirs, but had lost control of.
Julio Escalona
wiley   +1 more source

Honouring the Past, Embracing the Future

open access: yesThe Ecumenical Review, EarlyView.
Abstract The United Church of Canada, founded in 1925, represents an ambitious experiment in church union that blends Methodist, Presbyterian, and Congregationalist traditions. Over the past century, the church has played a pivotal role in shaping Canadian society by advocating for social justice, Indigenous reconciliation, interreligious dialogue ...
Hyuk Cho
wiley   +1 more source

Effect of bulb type on moth trap catch and composition in UK gardens

open access: yesInsect Conservation and Diversity, EarlyView.
We analyse 10 years of records Garden Moth Scheme (GMS) to estimate the effect of bulb and trap type on the number of moths caught by moth traps. We find that brighter, higher wattage bulbs collect the most moths. Heath traps catch fewer moths than Robinson or Skinner‐stye traps.
Reuben O'Connell‐Booth   +2 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

The Lancet, 2019
H. Gerstein   +499 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy